Enzymatic Nucleic Acid Detection via Restriction Endonuclease Cascade

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for detecting viral and microbial infections are often expensive, time-consuming, and require thermal cycling devices, limiting their accessibility and efficiency in diagnosing infections without the need for nucleic acid amplification techniques.

Innovation Solution

The use of an enzymatic amplification cascade of restriction endonucleases to detect nucleic acid of pathogens in biological samples, allowing for rapid, inexpensive, and sensitive detection of viral and microbial infections without the need for nucleic acid amplification techniques, using probe nucleic acids, recognition restriction endonucleases, and reporter nucleic acids to indicate the presence or absence of target nucleic acid.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If nucleic acid amplification techniques (e.g., PCR-based techniques) are used to detect viral or microbial infections, then detection sensitivity is improved, but device complexity and cost increase due to requirement for thermal cycling devices

Engineering Contradiction:
Improvedetection sensitivityVSAvoiddevice complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent replaces the mechanical/thermal cycling system (PCR-based techniques requiring thermal cyclers) with a biochemical cascade system using restriction endonucleases. The detection mechanism substitutes thermal amplification with enzymatic cleavage reactions that occur at constant temperature, eliminating the need for complex thermal cycling equipment while maintaining detection sensitivity through the cascade amplification effect of multiple restriction enzymes acting sequentially on the target nucleic acid.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Measurement precision

If nucleic acid amplification techniques are used to detect viral or microbial infections, then detection sensitivity is improved, but time required for diagnosis increases

Engineering Contradiction:
Improvedetection sensitivityVSAvoidtime required for diagnosis
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent implements continuous enzymatic action through a cascade of restriction endonucleases that act sequentially and continuously on the target nucleic acid molecules. Unlike discrete thermal cycling steps, the enzymatic cascade proceeds continuously at constant temperature, with each enzyme cleaving substrates and generating products that serve as substrates for subsequent enzymes, maintaining uninterrupted useful action and reducing total diagnosis time while preserving sensitivity.

Inventive Principle:
Principle #20Continuity of useful action

3Device complexity

If conventional detection methods are used, then equipment cost is reduced, but detection speed and efficiency decrease

Engineering Contradiction:
Improveequipment costVSAvoiddetection speed
Core Design Contradiction:
Device complexityVSProductivity

Solution Approach 1:

The patent changes the operational parameters from thermal cycling (temperature variation over time) to constant temperature enzymatic reactions. By shifting from time-temperature profile control to constant temperature biochemical catalysis, the system reduces equipment complexity and cost while increasing detection speed through the rapid, continuous enzymatic cleavage reactions that occur at optimal constant temperatures without the delays inherent in thermal cycling processes.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables rapid and cost-effective detection of viral and microbial infections, allowing for precise identification of pathogens in biological samples without the need for expensive equipment or time-consuming processes, facilitating early diagnosis and treatment.

Implementation Method 1

target nucleic acid present within the sample is capable of hybridizing to probe nucleic acid

Methodology Applied
Scientific EffectHybridization:

Implementation Method 2

contacting the double-stranded portion of nucleic acid with a recognition restriction endonuclease having the ability to cut the double-stranded portion of nucleic acid at the restriction endonuclease cut site

Methodology Applied
Scientific EffectEnzymatic cleavage: Enzyme

Data Source

PatentUS10113204B2Methods and materials for detecting viral or microbial infections
Publication Date: 2018.10.30 CASCADE BIOSYST
  • US10113204B2 patent drawing
  • US10113204B2 patent drawing
  • US10113204B2 patent drawing

AI summary

This document provides methods and materials for detecting target nucleic acid. For example, methods and materials for detecting the presence or absence of target nucleic acid, methods and materials for detecting the amount of target nucleic acid present within a sample, kits for detecting the presence or absence of target nucleic acid, kits for detecting the amount of target nucleic acid present within a sample, and methods for making such kits are provided.